arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up

Jaguar Health, Inc.

JAGX Health Care Biotechnology: Pharmaceutical Preparations
$3.67
▲ +0.3% Today
as of Oct 2, 16:50 ET
Last 30 days -73.45% Aug 26 → Oct 02
$0.13 $9.35 $18.56 $27.78 $37.00 Aug 26 Sep 02 Sep 10 Sep 18 Sep 25 Oct 02
Open
$4.15
High
$4.30
Low
$3.50
Volume
$583,508
Avg Vol
$312,766
Mkt Cap
$5M
P/E (TTM)
—
Beta
—
52w High
$1,267.88
52w Low
$2.35
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 14 items

▸ Show all 14 press releases & news Free account →

JAGX earnings at a glance

Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±10.1% on average; after the most recent report on May 20, 2026 it moved +9.4%. The share price of $3.67 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$2.35
$1.3K
0% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
-0.7%
50% positive

Earnings trends

EPS — actual vs estimate Actual Estimate
$-87.12$-65.94$-44.76$-23.57$-2.39 Actual $-2.39Actual $-41.35Actual $-22.50Actual $-87.12Actual $-2.66Actual $-26.29Actual $-16.70Actual $-10.26Actual $-6.28Actual $-13.60Actual $-15.70 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-13M$-4M$4M$13M$21M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-15.70 — — — — financials
Wed May 20, 2026Mar/2026 $-13.60 — — +18.6% +9.4% earnings
Fri Nov 14, 2025Sep/2025 $-6.28 — — — — earnings
Thu Aug 14, 2025Jun/2025 $-10.26 — — — — earnings
Thu May 15, 2025Mar/2025 $-16.70 — — — -10.9% earnings
Mon Sep 30, 2024Sep 2024 $-26.29 — — — — financials
Sun Jun 30, 2024Jun 2024 $-2.66 — — — — financials
Sun Mar 31, 2024Mar 2024 $-87.12 — — — — financials
Sat Sep 30, 2023Sep 2023 $-22.50 — — — — financials
Fri Jun 30, 2023Jun 2023 $-41.35 — — — — financials
Fri Mar 31, 2023Mar 2023 $-2.39 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$1M$20M—$3M$3M$2M—$3M
Cost of revenue$1M$1M—$532,000$527,000$515,000—$541,000
Gross profit————————
Operating income$-8M$10M—$-7M$-8M$-9M—$-7M
Net income$-13M$9M—$-10M$-11M$-11M—$-10M
EPS (diluted)$-15.70$-13.60—$-6.28$-358.94$-584.45—$-26.29

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$4M$7M$968,000$4M$2M$6M$8M$13M
Inventory$7M$8M$9M$11M$11M$11M$10M$10M
Total current assets$18M$20M$20M$29M$28M$30M$32M$37M
Total assets$34M$37M$38M$49M$48M$51M$53M$58M
Long-term debt————————
Total liabilities$29M$53M$57M$45M$41M$48M$44M$43M
Total equity$5M$-16M$-19M$4M$7M$830,000—$13M

Implied volatility — last 90 days

No IV snapshots yet for JAGX.

IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.

Sector peers

JAGX earnings FAQ

How does JAGX stock usually react to earnings?

Across the last 2 reports the average next-day move was ±10.1%, up 1 times and down 1 times.

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.